Christopher A. Morehouse

机构：Genmab (United States), AstraZeneca (South Korea), AstraZeneca (United States), AstraZeneca (Germany) · ORCID：0000-0003-1883-9894

发表论文 65 篇 · 总被引 3208 次 · h-index 21

代表论文

IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE (2018 · Nature Communications · 被引 602)
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction (2020 · Cell · 被引 560)
Patrolling Alveolar Macrophages Conceal Bacteria from the Immune System to Maintain Homeostasis (2020 · Cell · 被引 356)
Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non–Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab (2018 · Clinical Cancer Research · 被引 224)
Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data (2023 · The Lancet Infectious Diseases · 被引 118)
Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression (2014 · Journal of Clinical Investigation · 被引 117)